Deep Analysis — Capitol Development s.r.o. & MediFlow

Focus: Revenue composition, cost structure, team, and MediFlow economics. Confidence levels: Verified / Estimated / Assumed (per analysis rules).

1. How We Derive the Revenue Estimate

What Public Sources Say

Why the 2.5B CZK Figure is Wrong for Software

The 2018 detailed figure of ~2.576 billion CZK is not the software business. Evidence:

1. Capitol Dev Services (parent) shows nearly identical figures → data is consolidated or attributed to both entities by the aggregator
2. The parent was owned by BENEFITY a.s. (Sodexo/Pluxee employee benefits group) until Jun 2025
3. Parent's NACE codes = wholesale intermediation, not software
4. Payroll of 538M CZK for 10–19 employees = 28–54M CZK/person → impossible unless pass-through
5. Receivables of 345 days → typical for benefits voucher business (long settlement cycles), not software
6. The revenue bucket from the same source says 10–30M CZK → contradicts the detailed figure
7. Post-2019 (after Benefity separation), the bucket stays at 10–30M CZK, confirming software revenue

Best Estimate

Capitol Development s.r.o. software revenue: 15–25M CZK/year (€600K–1M)

This is based on:

• Consistent 10–30M CZK bucket classification (2015–2023)
• 15 employees with Czech software salaries (cost floor analysis below)
• Public contract revenue of only ~500K–900K CZK/year (most revenue is private sector)

2. Revenue Composition Model

Revenue Streams (per VOP / Terms & Conditions)

Capitol uses a hybrid licensing model (not pure SaaS):

MediFlow Revenue Estimate

Known: 4,700 installations in CZ+SK

Scenario modeling:

"Installation" ≠ "clinic." An installation is likely a single doctor workstation/license. A clinic with 5 doctors = 5 installations. So 4,700 installations could mean ~1,000–2,000 clinics.

Plus one-time revenue from new deployments:

• If ~200 new installations/year × license fee (est. 5,000–15,000 CZK) = 1–3M CZK
• Implementation services on new deployments: ~1–2M CZK

ProCES Revenue Estimate

Known: 23,471 users, 37,250 monthly requests, 95,280 annual approved bonuses

ProCES has "unlimited user accounts" per their marketing — suggesting per-company licensing, not per-user.

MAX Revenue Estimate

Known: 74,082 monthly examination orders, used by 120+ doctors in Vysočina Region

Likely bundled with MediFlow or sold to regional health authorities. Revenue contribution: estimated 1–3M CZK/year.

EGAP & Other Non-Healthcare

From public contracts:

• EGAP (export guarantee agency): website + support = ~200K–800K CZK/year
• Other project work: ~0.5–1M CZK/year

Total Revenue Model

Best estimate: ~20–25M CZK/year, weighted toward MediFlow recurring.

The 10–30M bucket from detail.cz aligns perfectly with the mid scenario.

3. Cost Structure

Personnel Costs (largest cost item)

Headcount: ~15 people (Atmoskop), 10–19 range (registries)

Current hiring: PHP developer, IT consultant, PM, tester, analyst — this likely represents the full role mix.

Estimated team composition:

Best estimate: ~15M CZK/year personnel costs

Czech salary references (Prague, 2025–2026):

• PHP developer average: ~60K–80K CZK/month gross (Glassdoor)
• Senior PHP: ~80K–120K CZK/month
• Employer costs add ~34% (social 24.8% + health 9%)

Other Operating Costs

P&L Model (Estimated)

At 15M revenue the company barely breaks even or loses money. At 22M+ it's modestly profitable. At 30M it's a healthy small software business.

4. MediFlow Product Deep-Dive

What It Is

Feature Set

Clinical:

• Process modeling for clinical workflows across specialties
• Centralized patient data access
• Performance evaluation and comparative reporting
• Examination ordering (via MAX integration)

Compliance:

• eRecept (electronic prescriptions) — Czech eHealth mandate
• eNeschopenka (electronic sick leave) — Czech eHealth mandate
• EET (electronic records of sales) — fiscal compliance

Payments:

• Cash, cashless, card payment processing
• Likely insurance billing (pojišťovny) — not explicitly stated but essential

Technical:

• Web-based, requires only browser
• Can run on internal infra or internet
• PHP backend (from hiring page)
• Cloud-capable
• 12 language versions with automated translation

What's Missing (Red Flags)

The website is quite sparse on technical details. These may exist but aren't marketed. Needs DD verification.

Competitive Position

5. Known Customers & Contracts

Verified Customers (from Hlídač Státu + press)

Inferred Customer Base

• Vysočina Region hospitals: Třebíč, Pelhřimov, Nové Město na Moravě, Jihlava — 120+ doctors on MAX, 30,000+ eAmbulance users
• Private ambulatory clinics: Bulk of 4,700 installations — individual doctors and small clinics across CZ+SK
• Enterprise clients: ProCES users (23,471) — likely 20–50 companies

Revenue from Public Sector

Only ~3M CZK total (2017–2026) in the public contract register → >90% of revenue is from the private sector (individual clinics, private practices, commercial enterprises).

This is both:

• Positive: Not dependent on public procurement cycles
• Risk: Harder to verify revenue (no public records of private contracts)

6. People & Organization

Confirmed Individuals

Team Profile

Key-Person Risk Assessment

7. CRITICAL NEW FINDINGS (Gap Analysis Update)

7.1 Capitol BUILT the Benefity.cz Platform (!)

This changes the entire revenue picture. Capitol Development is the developer and operator of the Benefity.cz cafeteria/employee benefits platform — not merely a user.

Evidence:

• Mobile apps "Benefity (nové)" and "Naše stravenka" are published under Capitol Development's App Store developer account (ID: 1391695124)
• Bundle ID: cz.capitol.benefity.newapp
• Google Play package: cz.capitol.benefity.newapp
• Benefity.cz serves 1,500+ corporate clients and was the first online cafeteria system in CZ

Implications:

• The reported 10–30M CZK revenue may include Benefity platform maintenance revenue, not just MediFlow/ProCES
• After the June 2025 separation from BENEFITY a.s. (now Pluxee/Sodexo), Capitol may still maintain the platform under contract
• If Benefity maintenance = 50% of revenue, then MediFlow revenue is only 5–15M CZK

Critical DD question: Does Capitol still maintain Benefity.cz for Pluxee post-separation? What are the contract terms?

7.2 Market Sizing — 25,267 Ambulatory Offices in CZ

MediFlow TAM (excluding dental): ~19,674 offices

MediFlow penetration: 4,700 / 19,674 = ~24% (if all installations are CZ)

TAM at 300 CZK/month: 19,674 × 300 × 12 = 70.8M CZK/year

Key trend: GP offices declining 10–20% since 2016 (physician retirement). Remaining practices need MORE efficiency software. Market shrinking by count but growing by value per practice.

7.3 Mobile Development Capability Confirmed

Capitol has published iOS + Android apps with:

• Biometric login (Face ID / Touch ID)
• QR/barcode display
• GPS-based supplier maps
• Transaction management

This is more sophisticated than "just PHP" — confirms broader tech stack.

7.4 Vysočina Region — MAX is the Booking Layer, Not the NIS

Clarification: Capitol's role is the patient booking and doctor communication layer (MAX). The eAmbulance portal (portal.eambulance.cz) was actually built by Scalesoft/STAPRO (branded "FONS Portál pacienta"), NOT Capitol. Capitol provides the MAX backend for doctor-to-doctor referrals and ordering. The core hospital NIS was awarded to STAPRO in a 116M+ CZK contract (2020).

Verified: eAmbulance portal credits Scalesoft, not Capitol. Capitol's contribution is the MAX communication layer used by 120+ doctors.

• eAmbulance: 30,000+ patients, covers all 5 Vysočina hospitals
• MAX: 120+ doctors for automated referrals
• Capitol provides technical support (line: 840 108 108)
• Capitol and STAPRO coexist but don't compete at the NIS level

7.5 Salary Data Validated

Czech salary benchmarks (Prague, 2025-2026) confirm our cost model:

Employer cost multiplier: ×1.34 (24.8% social + 9% health)

Our 15M CZK/year personnel cost estimate is confirmed — confidence upgraded from Estimated to Sourced.

7.6 Tomáš Hubáček — Sales Executive, NOT Technologist

Assessment: His departure is NOT a key-person risk for product development. He was the commercial/sales bridge from the Benefity era. The question is: who handles sales and customer relationships now?

7.7 Vladimír Beran — AI Ambassador from Etnetera Core (!)

This is a MAJOR POSITIVE signal. Beran brings enterprise-grade software experience from one of CZ's most respected development companies. His AI focus aligns with healthcare IT modernization trends. He's publicly known for the "Poslední ping" project — an autonomous server managed entirely by Claude Code AI, covered by CzechCrunch, Lupa.cz, Root.cz, and OSEL.cz.

His vision: "Teams will gradually shrink to a single person who acts like a conductor directing dozens of specialized AI agents."

Risk: He holds dual roles (Etnetera + Capitol) — likely advisory/part-time. No public mention of Capitol or healthcare in his interviews.

Strategic question: Is Etnetera a potential partner/acquirer? Beran's appointment could signal a technology modernization initiative backed by Etnetera's 200-person engineering team.

7.8 Filip Charvát — Healthcare Operations Executive + PE

Mediterra hospitals: C.L.P.A. Malvazinky Rehab Clinic, Mělník Hospital, Mostiště Hospital, Palackého Polyclinic, Sedlčany Hospital, Tanvald Hospital

Assessment: Charvát bridges healthcare delivery (Mediterra) and healthcare IT (Capitol/MediFlow). His Private Equity Prague involvement suggests the Capitol acquisition was structured with PE-style thinking.

7.9 "Medeor" — Possible Fourth Product Line

Contracts with Endokrinologický ústav explicitly name "Medeor" (not MediFlow):

• "Medeor - modul ePoukazy" (eVouchers module)
• "Medeor - Migrace na nový server" (server migration)

Medeor is NOT listed on Capitol's website. It has modular architecture and its own server infrastructure → likely a separate codebase for institutional healthcare (vs. MediFlow for private ambulatory).

Verified: The klient.endo.cz portal footer reads "Programmed by Capitol Development". It uses jQuery/jQuery UI frontend, reCAPTCHA, and offers patient features: membership programs, appointment scheduling, exam results, prescriptions, and medical documentation. This is the "Medeor" system in action.

Capitol's actual product portfolio may be:

1. MediFlow (ambulatory/hospital IS)
2. ProCES (enterprise process management)
3. MAX (medical automated communication)
4. Medeor (institutional healthcare IS)
5. Benefity platform (cafeteria/benefits system)
6. EGAP website (custom web development)

This is more diversified than initially understood — both a strength (multiple revenue streams) and a risk (attention spread thin across 5+ products with 15 people).

8. Summary: What We Know vs. What We Don't

Confidence Matrix

The Five Questions That Determine Price

1. Does Capitol still maintain Benefity.cz for Pluxee? (could be 50%+ of revenue)
2. What is MediFlow-specific revenue vs. Benefity platform revenue? (changes valuation entirely)
3. Is revenue closer to 15M or 30M CZK? (2x difference in valuation)
4. What is the annual churn on 4,700 installations? (determines sustainability)
5. Will Capitol invest in FHIR/EHDS compliance? (mandatory by ~2028, existential risk)

Getting the audited účetní závěrka for Capitol Development (2019–2024) is the single most important next step. These should exist but are not filed in sbírka listin — the company or seller must provide them.

Second most important: Clarify the Benefity.cz maintenance contract status with Pluxee — this could double or halve the implied MediFlow valuation.